Elevated sCD163 levels are positively associated with HIV-NHL risk in a dose-dependent manner, especially in PCNSL [7], suggesting that it may be involved in virus-driven tumorigenesis, particularly EBV-associated PCNSL [103]. The gene discussed is CD163; the disease is non-Hodgkin lymphoma.